SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 291 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $50,000 | -5.7% | 1,500 | 0.0% | 0.01% | -14.3% |
Q1 2019 | $53,000 | +6.0% | 1,500 | 0.0% | 0.01% | 0.0% |
Q4 2018 | $50,000 | -34.2% | 1,500 | 0.0% | 0.01% | -30.0% |
Q3 2018 | $76,000 | -15.6% | 1,500 | 0.0% | 0.01% | -23.1% |
Q2 2018 | $90,000 | +30.4% | 1,500 | 0.0% | 0.01% | +30.0% |
Q1 2018 | $69,000 | +15.0% | 1,500 | 0.0% | 0.01% | +11.1% |
Q4 2017 | $60,000 | -25.0% | 1,500 | -25.0% | 0.01% | -25.0% |
Q3 2017 | $80,000 | -7.0% | 2,000 | 0.0% | 0.01% | -7.7% |
Q2 2017 | $86,000 | +36.5% | 2,000 | 0.0% | 0.01% | +30.0% |
Q1 2017 | $63,000 | +23.5% | 2,000 | 0.0% | 0.01% | +11.1% |
Q4 2016 | $51,000 | +4.1% | 2,000 | 0.0% | 0.01% | 0.0% |
Q3 2016 | $49,000 | +19.5% | 2,000 | 0.0% | 0.01% | +12.5% |
Q2 2016 | $41,000 | +32.3% | 2,000 | 0.0% | 0.01% | +60.0% |
Q1 2016 | $31,000 | – | 2,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
S&T BANK/PA | 215,578 | $5,943 | 1.15% |
Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |